36-months real-world experience in patients with refractory chronic diabetic macular edema (DME) treated with the 190 micrograms fluocinolone acetonide intravitreal implant (ILUVIEN).

Putri Christine Anggun; Quhill Fahd

首页> 外文期刊>Investigative ophthalmology & visual science >36-months real-world experience in patients with refractory chronic diabetic macular edema (DME) treated with the 190 micrograms fluocinolone acetonide intravitreal implant (ILUVIEN).

【24h】

36-months real-world experience in patients with refractory chronic diabetic macular edema (DME) treated with the 190 micrograms fluocinolone acetonide intravitreal implant (ILUVIEN).

机译：36个月的真实世界患者患者难治性慢性糖尿病黄斑水肿（DME）的经验，用190微克氟氨基醇醋酸纤维素植入物（ILUVIEN）治疗。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Investigative ophthalmology & visual science》 |2018年第9期|共1页
作者
Putri Christine Anggun; Quhill Fahd;
展开▼
作者单位

Sheffield Teaching Hosp NHS Fdn Trust Ophthalmol Sheffield S Yorkshire England;

Sheffield Teaching Hosp NHS Fdn Trust Ophthalmol Sheffield S Yorkshire England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. 36-months real-world experience in patients with refractory chronic diabetic macular edema (DME) treated with the 190 micrograms fluocinolone acetonide intravitreal implant (ILUVIEN). [J] . Putri Christine Anggun, Quhill Fahd Investigative ophthalmology & visual science . 2018,第9期

机译：36个月的真实世界患者患者难治性慢性糖尿病黄斑水肿（DME）的经验，用190微克氟氨基醇醋酸纤维素植入物（ILUVIEN）治疗。
2. The use of fluocinolone acetonide implant(ILUVIEN) in patients with diabetic macular edema(DME) previously treated with dexamethasone intravitreal implant(OZURDEX) - Efficacy and safety outcomes from clinical practice in Glasgow, Scotland [J] . Rajasekaran Sridevi, Mulla Umaima, Drummond Suzannah, Investigative ophthalmology & visual science . 2017,第8期

机译：使用糖尿病黄斑水肿（DME）患者使用嗜血体植物植入物（ILUVIEN）以前用地塞米松玻璃体植入物（Ozurdex） - 来自苏格兰格拉斯哥临床实践的疗效和安全结果
3. The use of fluocinolone acetonide implant(ILUVIEN) in patients with diabetic macular edema(DME) previously treated with dexamethasone intravitreal implant(OZURDEX) - Efficacy and safety outcomes from clinical practice in Glasgow, Scotland [J] . Rajasekaran Sridevi, Mulla Umaima, Drummond Suzannah, Investigative ophthalmology & visual science . 2017,第8期

机译：使用糖尿病黄斑水肿（DME）患者使用嗜血体植物植入物（ILUVIEN）以前用地塞米松玻璃体植入物（Ozurdex） - 来自苏格兰格拉斯哥临床实践的疗效和安全结果
4. Pharmacokinetic Modeling to Improve the Design of Intravitreal Corticosteroid Implants for Treating Macular Edema [C] . Susan S. Lee, David Z. DArgenio, Rex A. Moats, Controlled Release Society Annual Meeting and Exposition . 2007

机译：药物动力学模型可改善玻璃体皮质类固醇植入物治疗黄斑水肿的设计
5. Three-year results from the Retro-IDEAL study: Real-world data from diabetic macular edema (DME) patients treated with ILUVIEN® (0.19 mg fluocinolone acetonide implant) [O] . Albert J Augustin, Silvia Bopp, Martin Fechner, -1

机译：Retro-IDEAL研究的三年结果：接受ILUVIEN®（0.19mg氟轻松的丙酮酸植入物）治疗的糖尿病性黄斑水肿（DME）患者的真实数据
6. Clinical utility of intravitreal fluocinolone acetonide (Iluvien®) implant in the management of patients with chronic diabetic macular edema:a review of the current literature [O] . Saedon, Habiba, Anand, Astha, Yit, Yang C. 2017

机译：玻璃体腔注射氟轻松的临床应用（Iluvien®）在慢性糖尿病性黄斑水肿患者管理中的应用

36-months real-world experience in patients with refractory chronic diabetic macular edema (DME) treated with the 190 micrograms fluocinolone acetonide intravitreal implant (ILUVIEN).

著录项

相似文献

相关主题

期刊订阅